AIFM2 and central nervous system cancer: The analysis of mRNA expression profiles of glioma samples and non-tumor brain tissues provided evidence that GPX4, FSP1, and DHODH were highly expressed in tumoral tissue compared to that in non-tumor brain tissues (Figure 1E and Supplementary Figures 1A,B).